Ischaemic preconditioning and mast cell histamine release: Microdialysis of isolated rat hearts

Pharmacological Research

Volumn 45, Issue 5, 2002, Pages 383-390

  Davani, Siamak ^a   Muret, Patrice ^a   Royer, Bernard ^a   Kantelip, Bernadette ^a   Frances, Carole ^b   Millart, Hervé ^b   Kantelip, Jean Pierre ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

Arrhythmias; Histamine; Ischaemic preconditioning; Microdialysis

Indexed keywords

CROMOGLYCATE DISODIUM; HISTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; HEART ARRHYTHMIA; HEART INFARCTION PREVENTION; HEART MUSCLE REPERFUSION; HISTAMINE RELEASE; ISOLATED HEART; KINETICS; MALE; MAST CELL; MAST CELL DEGRANULATION; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0036426711     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0960     Document Type: Article

References (27)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: A delay of lethal cell injury in ischaemic myocardium. Circulation 1986; 74: 1124-36.
2. Asimakis GK, Inners-McBride K, Medellin G, Conti VR. Ischaemic preconditioning attenuates acidosis and postischaemic dysfunction in isolated rat heart. Am J Physiol 1992; 263: H887-94.
3. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-6.
4. Sharma A, Singh M. Possible mechanism of cardioprotective effect of ischaemic preconditioning in isolated rat heart. Pharmacol Res 2000; 41: 635-40.
5. Banerjee A, Locke-Winter C, Rogers KB, Mitchell MB, Brew EC, Cairns CB, Bensard DD, Harken AH. Preconditioning against myocardial dysfunction after ischaemia and reperfusion by an alpha 1-adrenergic mechanism. Circ Res 1993; 73: 656-70.
6. Wall TM, Sheehy R, Hartman JC. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994; 270: 681-9.
7. Dorheim TA, Wang T, Mentzer RM, Van Wylen DG. Interstitial purine metabolites during regional myocardial ischaemia. J Surg Res 1990; 48: 491-7.
8. Valen G, Kaszaki J, Szabo I, Nagy S, Vaage J. Toxic oxygen metabolites and ischaemia-reperfusion increase histamine synthesis and release in the isolated rat heart. J Mol Cell Cardiol 1993; 25: 31-40.
9. Parikh V, Singh M. Resident cardiac mast cells and the cardioprotective effect of ischaemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 1997; 30: 149-56.
10. Wang P, Downey JM, Cohen MV. Mast cell degranulation does not contribute to ischaemic preconditioning in isolated rabbit hearts. Basic Res Cardiol 1996; 91: 458-67.
11. Humphreys RA, Kane KA, Parratt JR. Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats. J Cardiovasc Pharmacol 1998; 31: 418-23.
12. Queneau PE, Sauve G, Royer B, Viennet G, Kantelip B, Miguet JP, Mantion G, Carayon P. Histamine-producing neuroendocrine tumor of the ampulla of Vater. Gastroenterol Clin Biol 1999; 23: 1245-7.
13. Keller AM, Clancy RM, Barr ML, Marboe CC, Cannon PJ. Acute reoxygenation injury in the isolated rat heart: Role of resident cardiac mast cells. Circ Res 1988; 63: 1044-52.
14. Campos BG, Ferreira RR, Gomes JC. The potentiation of the histamine release induced by adenosine in mast cells from guinea pig lung and heart: Sharp dependence on the time of preincubation. Pharmacol Res 2000; 41: 291-7.
15. Parikh V, Singh M. Cardiac mast cell stabilization and cardioprotective effect of ischaemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 1998; 31: 779-85.
16. Van Haaster CM, Engels W, Duijvestijn AM, Lemmens PJ, Hornstra G, Van der Vusse GJ. Lack of evidence for a role of mast cell degranulation in acute hypoxia/reoxygenation-induced injury in the isolated rat heart. J Mol Cell Cardiol 1996; 28: 363-73.
17. Van Wylen DG, Williams AG Jr, Downey HF. Interstitial purine metabolites and lactate during regional myocardial hypoxia. Cardiovasc Res 1993; 27: 1498-503.
18. Linden J. Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functions. TIPS 1994; 15: 298-306.
19. Osada M, Sato T, Komori S, Tamura K. Protective effect of preconditioning on reperfusion induced ventricular arrhythmias of isolated rat hearts. Cardiovasc Res 1991; 25: 441-4.
20. Ramkumar V, Stiles GL, Beaven MA, Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 1993; 268: 16887-90.
21. Imamura M, Lander HM, Levi R. Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischaemia. Comparison with adenosine A1-receptors and alpha2-adrenoreceptors. Circ Res 1996; 78: 475-81.
22. Parikh V, Singh M. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection. Pharmacol Res 1999; 40: 129-37.
23. Kurz T, Offner B, Schreieck J, Richardt G, Tolg R, Schomig A. Nonexocytotic noradrenaline release and ventricular fibrillation in ischaemic rat hearts. Naunyn Schmiedebergs Arch Pharmacol 1995; 352: 491-6.
24. Shiki K, Hearse DJ. Preconditioning of ischaemic myocardium: Reperfusion-induced arrhythmias. Am J Physiol 1987; 253: H1470-6.
25. Miyatake Y, Kusama Y, Kishida H, Hayakawa H. Adenosine mediates the antiarrhythmic effect of ischaemic preconditioning in isolated rat hearts. Jpn Circ J 1996; 60: 341-8.
26. Schreieck J, Richardt G. Endogenous adenosine reduces the occurrence of ischaemia-induced ventricular fibrillation in rat heart. J Mol Cell Cardiol 1999; 31: 123-34.
27. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM. The Lambeth conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988; 22: 447-55.